Stimulating drugs in Alzheimer's disease.
Stewart
A
A
D000544:Alzheimer Disease / Q000188:drug therapy*; D062365:Aminobenzoates; D001921:Brain / Q000187:drug effects; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D007042:Hypoxanthines; D009474:Neurons / Q000187:drug effects; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011687:Purines / Q000627:therapeutic use*
D062365:Aminobenzoates; D007042:Hypoxanthines; D011619:Psychotropic Drugs; D011687:Purines; C086241:4-((3-(1,6-dihyro-6-oxo-9H-purin-9-yl)-1-oxopropyl)amino)benzoic acid